SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-15-000015
Filing Date
2015-11-04
Accepted
2015-11-04 16:36:19
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-093015x10q.htm 10-Q 951859
2 EXHIBIT 31.1 ebio-093015x311.htm EX-31.1 12039
3 EXHIBIT 31.2 ebio-093015x312.htm EX-31.2 11905
4 EXHIBIT 32.1 ebio-093015x321.htm EX-32.1 6956
  Complete submission text file 0001485003-15-000015.txt   3517253

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20150930.xml EX-101.INS 574660
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20150930.xsd EX-101.SCH 26232
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20150930_cal.xml EX-101.CAL 40968
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20150930_def.xml EX-101.DEF 91743
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20150930_lab.xml EX-101.LAB 368902
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20150930_pre.xml EX-101.PRE 202433
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 151197421
SIC: 2834 Pharmaceutical Preparations